The legacy of Viagra, and its developer copyright, presents a intriguing case study for investors. At first a blockbuster drug, yielding billions in revenue , its patent expiration created a flood of https://bookmarkmoz.com/story21427588/sildenafil-and-big-pharma-a-risky-opportunity